A Tool to Estimate the Absolute Risk of Neonatal Respiratory Morbidity in the Late Preterm Period
Using data from the ALPS Trial, we developed a tool to estimate the absolute risk of respiratory morbidity with and without antenatal steroid exposure in the late preterm period based on two clinical factors: planned mode of delivery and gestational age at presentation. More details about this tool’s development can be found in our manuscript, currently posted on medrxiv.org and submitted for peer-reviewed publication.
The tool, which is illustrated below, can be accessed online at: https://mghinferencelab.shinyapps.io/alps_web_calc/
mgh obgyn inference lab 